Abstract
Background
Gut microbiota plays a significant role in the pathogenesis of non-alcoholic fatty liver disease (NAFLD). This study aimed to assess the contribution of gut microbiota dysbiosis to the pathogenesis of NAFLD.Methods
Forty-seven human feces samples (25 NAFLD patients and 22 healthy subjects) were collected and 16S rDNA amplicon sequencing was conducted on Hiseq 2000 platform. Discrepancy of species composition between controls and NAFLD group was defined by Metastats analysis under P value <0.01.Results
NAFLD patients harbored lower gut microbiota diversity than healthy subjects did. In comparison to the control group, the Proteobacteria (13.50%) and Fusobacteria (2.76%) phyla were more abundant in NAFLD patients. Additionally, the Lachnospiraceae (21.90%), Enterobacteriaceae (12.02%), Erysipelotrichaceae (3.83%), and Streptococcaceae (1.39%) families, as well as the Escherichia_Shigella (10.84%), Lachnospiraceae_Incertae_Sedis (7.79%), and Blautia (4.95%) genera were enriched in the NAFLD group. However, there was a lower abundance of Prevotella in the NAFLD group than that in the control group (5.83% vs 27.56%, P<0.01). The phylum Bacteroidetes (44.63%) also tended to be more abundant in healthy subjects, and the families Prevotellaceae (28.66%) and Ruminococcaceae (26.44%) followed the same trend. Compared to those without non-alcoholic steatohepatitis (NASH), patients with NASH had higher abundance of genus Blautia (5.82% vs 2.25%; P=0.01) and the corresponding Lachnospiraceae family (24.33% vs 14.21%; P<0.01). Patients with significant fibrosis had a higher abundance of genus Escherichia_Shigella (12.53% vs 1.97%; P<0.01) and the corresponding Enterobacteriaceae family (13.92% vs 2.07%; P<0.01) compared to those with F0/F1 fibrosis.Conclusions
NAFLD patients and healthy subjects harbor varying gut microbiota. In contrast to the results of previous research on children, decreased levels of Prevotella might be detrimental for adults with NAFLD. The increased level of the genus Blautia, the family Lachnospiraceae, the genus Escherichia_Shigella, and the family Enterobacteriaceae may be a primary contributor to NAFLD progression.References
Articles referenced by this article (34)
Gut microbiota and non-alcoholic fatty liver disease: new insights.
Clin Microbiol Infect, (4):338-348 2013
MED: 23452163
Gut--liver axis: the impact of gut microbiota on non alcoholic fatty liver disease.
Nutr Metab Cardiovasc Dis, (6):471-476 2012
MED: 22546554
Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease.
Hepatology, (6):1877-1887 2009
MED: 19291785
Elevated endotoxin levels in non-alcoholic fatty liver disease.
J Inflamm (Lond), 15 2010
MED: 20353583
Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH.
Hepatology, (2):601-609 2013
MED: 23055155
t10,c12 conjugated linoleic acid upregulates hepatic de novo lipogenesis and triglyceride synthesis via mTOR pathway activation.
J Microbiol Biotechnol, (11):1569-1576 2013
MED: 24018969
Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice.
Proc Natl Acad Sci U S A, (33):12511-12516 2006
MED: 16895997
Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5.
Science, (5975):228-231 2010
MED: 20203013
Show 10 more references (10 of 34)
Citations & impact
Impact metrics
Article citations
Metagenome-based characterization of the gut bacteriome, mycobiome, and virome in patients with chronic hepatitis B-related liver fibrosis.
Front Microbiol, 15:1449090, 25 Oct 2024
Cited by: 0 articles | PMID: 39526142
Therapeutic Role of Probiotics Against Environmental-Induced Hepatotoxicity: Mechanisms, Clinical Perspectives, Limitations, and Future.
Probiotics Antimicrob Proteins, 24 Sep 2024
Cited by: 0 articles | PMID: 39316257
Review
The impact of traditional Chinese medicine and dietary compounds on modulating gut microbiota in hepatic fibrosis: A review.
Heliyon, 10(19):e38339, 26 Sep 2024
Cited by: 0 articles | PMID: 39391468 | PMCID: PMC11466535
Review Free full text in Europe PMC
Epidemiological Study on the Interaction between the <i>PNPLA3</i> (rs738409) and Gut Microbiota in Metabolic Dysfunction-Associated Steatotic Liver Disease.
Genes (Basel), 15(9):1172, 06 Sep 2024
Cited by: 0 articles | PMID: 39336763 | PMCID: PMC11430940
Causal relationship between gut microbiota and male erectile dysfunction: a Mendelian randomization analysis.
Front Microbiol, 15:1367740, 29 Aug 2024
Cited by: 0 articles | PMID: 39268537 | PMCID: PMC11390668
Go to all (247) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Microbiome Signatures Associated With Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease.
Gastroenterology, 157(4):1109-1122, 27 Jun 2019
Cited by: 127 articles | PMID: 31255652 | PMCID: PMC6756995
Gut microbiota and non-alcoholic fatty liver disease.
Hepatobiliary Pancreat Dis Int, 14(6):572-581, 01 Dec 2015
Cited by: 36 articles | PMID: 26663004
Review
The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota.
Hepatology, 63(3):764-775, 13 Jan 2016
Cited by: 689 articles | PMID: 26600078 | PMCID: PMC4975935
Gut Microbiota Dysbiosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study in Taiwan.
Nutrients, 12(3):E820, 19 Mar 2020
Cited by: 47 articles | PMID: 32204538 | PMCID: PMC7146257